NMRA

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

• Neumora reported Phase 3 KOASTAL program data and provided an update on its business and pipelineJun 15, 2026
• Neumora Therapeutics reports positive results from NMRA-511 Phase 1b signal-seeking study in Alzheimer’s disease agitationJan 5, 2026
• Neumora Therapeutics announces initiation of Phase 1 clinical study of M4 positive allosteric modulator NMRA-898Oct 27, 2025
• Neumora Therapeutics initiates Phase 1 clinical study of M4 positive allosteric modulator NMRA-861Jul 9, 2025